Validra Clinical Compliance Ltd conducts independent, risk-based GCP audits using a structured and consistent methodology aligned with ICH-GCP E6 (R2) and guided by recognised auditing principles, including ISO 19011.
Our methodology is designed to provide objective, defensible assurance while remaining proportionate to the scope, risk, and nature of the activities audited.
All audits conducted by Validra are based on the following core principles:
These principles underpin every stage of the audit lifecycle.
Each audit begins with a clear definition of scope and objectives, agreed in advance with the client.
This includes:
Where appropriate, a risk-based rationale is applied to focus audit effort on areas of highest potential impact.
Audits are planned in a structured and documented manner.
Planning activities include:
Audit plans remain flexible and may be adjusted during the audit based on emerging risk or availability of evidence.
Audits are conducted using recognised audit techniques, including:
Remote audits utilise secure document sharing and video conferencing, with limitations clearly defined where physical verification is not within scope.
All audit activities focus on the collection of objective evidence.
Audit observations are evaluated against applicable requirements and classified using a structured approach.
Findings are:
This ensures findings are proportionate, consistent, and meaningful.
A formal GCP Audit Report is issued following completion of the audit.
Reports include:
Reports are written to support sponsor oversight, internal quality improvement, and regulatory readiness.
Where CAPAs are required, Validra can support:
Audit closure activities are conducted independently from audit delivery.
To maintain audit integrity:
This ensures audit outcomes are objective, credible, and defensible.
Validra’s methodology is designed to deliver meaningful assurance, not unnecessary burden.
Our audits provide: